Search

Search Constraints

You searched for: Author/Creator Schmelter, Thomas

Search Results

1. A Double‐Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl‐L‐Carnitine in the Prevention of Sagopilone‐Induced Peripheral Neuropathy. (8th October 2013)

2. Corrigendum to "Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use" [Eur J Obstetr Gynecol Reprod Biol 210 (2017) 22–28]. (February 2019)

3. Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). Issue 3 (29th November 2022)

4. EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study. Issue 9 (September 2021)

5. EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN. Issue 5 (May 2019)

6. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use. (March 2017)

8. Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial. (January 2023)

9. INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial. Issue 6 (22nd June 2022)

10. Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non–Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens. Issue 12 (December 2015)